In addition, IMPAD1‐overexpressing PC9 cells showed high sensitivity to gefitinib, afatinib or osimertinib compared with the control cells (Figure S5B), which was similar to the PC9 cells with BC knockout. The gene discussed is BPNT2; the disease is breast cancer.